JSTL:BSEJeevan Scientific Technology Ltd Analysis
Data as of 2026-03-14 - not real-time
₹59.88
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
JSTL is trading at ₹59.88, just above the computed support of ₹58.70 and well below its 20‑day (₹67.39) and 50‑day (₹66.54) SMAs, indicating a short‑term downtrend. The RSI of 35.2 suggests the stock is approaching oversold territory, yet the MACD is bearish with the line below the signal, and the 30‑day volatility is a lofty 42%. Despite a very low systematic beta (≈0.07), the price action reflects heightened idiosyncratic risk.
On the fundamentals side, revenue surged 52.5% YoY, and gross margins are strong at 90%, but the company posted a negative net profit margin of -3.7% and zero earnings per share. Debt is sizable at a Debt‑to‑Equity of 52.8 with minimal cash reserves, while valuation multiples (P/B ~2.0, P/S ~2.37) appear modest relative to the sector. The blend of strong top‑line growth and weak profitability, coupled with high leverage, paints a cautious outlook.
On the fundamentals side, revenue surged 52.5% YoY, and gross margins are strong at 90%, but the company posted a negative net profit margin of -3.7% and zero earnings per share. Debt is sizable at a Debt‑to‑Equity of 52.8 with minimal cash reserves, while valuation multiples (P/B ~2.0, P/S ~2.37) appear modest relative to the sector. The blend of strong top‑line growth and weak profitability, coupled with high leverage, paints a cautious outlook.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Price below short‑term moving averages
- Bearish MACD and high short‑term volatility
- Negative net earnings and limited cash
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Robust revenue growth and high gross margin
- Elevated debt load and zero free cash flow
- Support level near current price offering limited upside
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- Sustained profitability challenges
- High leverage without clear cash‑flow improvement
- Sector’s regulatory and competitive headwinds
Key Metrics & Analysis
Financial Health
Revenue Growth52.50%
Profit Margin-3.74%
Debt/Equity52.79
P/B Ratio2.0
Industry P/E26.2
Technical Analysis
TrendBullish
RSI35.2
Support₹58.70
Resistance₹72.50
MA 20₹67.39
MA 50₹66.54
MA 200₹52.22
MACDBearish
VolumeStable
Fear & Greed Index72.88
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta0.07
Volatility42.00%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.